Objective: To determine the efficacy and tolerability of low-dose tamsulosin 0.2 mg/day in Chinese patients with symptomatic benign prostatic hyperplasia (BPH). Conclusions: Low-dose tamsulosin 0. ...

tamsulosin monotherapy, economic analyses have been conducted in the UK, [10] Canada, [11] Spain, [12] and Scandinavia, [13] where the fixed-dose combination therapy was shown to be cost-effective ...

New data have prompted calls for the safety information provided with tamsulosin tablets to be reassessed. Blockade of α 1a-adrenergic receptors in the smooth muscle of the prostate and bladder ...

These vascular effects can, however, be greatly reduced by the use of the α 1a receptor antagonist tamsulosin, which specifically targets urothelial smooth muscle. α-Blockers are not yet ...

Due to first-dose hypotension, these drugs are usually taken at night to lessen the side-effects. Tamsulosin and alfuzosin are less selective towards arterial alpha receptors and thus have less of ...